Devonian Health Group Inc. (TSXV:GSD)
Canada · Delayed Price · Currency is CAD 7.74
+0.24 (3.20%)
Oct 30, 2026, 9:30 AM EDT
Devonian Health Group Market Cap
Devonian Health Group has a market cap or net worth of CAD 21.52 million as of October 30, 2026. It is the 38,593rd most valuable company in the world and the 1,255th biggest in Canada. Its market cap has decreased by 13.53% in one year.
Market Cap
21.52M
Enterprise Value
20.94M
Revenue
3.00M
Global Rank
Country Rank
#1,255 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since May 19, 2017, Devonian Health Group's market cap has decreased from 1.44B to 21.52M, a decrease of -98.51%. That is a compound annual growth rate of -35.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 21.52M | -31.73% |
| Dec 24, 2025 | 31.53M | 32.95% |
| Dec 30, 2024 | 23.72M | 11.47% |
| Dec 21, 2023 | 21.28M | -52.33% |
| Dec 21, 2022 | 44.63M | -94.11% |
| Dec 31, 2021 | 758.36M | 359.02% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ME Therapeutics Holdings | 33.43M |
| Resverlogix | 27.54M |
| Defence Therapeutics | 26.53M |
| Telescope Innovations | 25.06M |
| The More Life Company | 22.85M |
| Onco-Innovations | 18.69M |
| Pharmala Biotech Holdings | 17.55M |
| Rapid Dose Therapeutics | 15.16M |